PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
24-Dec-2024 Fuel Resistant Coatings: A Simple Solution for Big Problems! Acumen Research and Consulting
23-Dec-2024 Telomir Pharmaceuticals Confirms Copper Binding Capabilities of Telomir-1 and Expands Pipeline Into Wilson's Disease Newswire
20-Dec-2024 Quantum Biopharma Diversifies Treasury With the Purchase of USD $1,000,000 of Bitcoin (BTC) and Other Cryptocurrencies and to Allow for Future Financings and Other Transactions in Cryptocurrency Newswire
19-Dec-2024 Zepbound Coupons and Discounts From Duty Free Meds Newswire
19-Dec-2024 MIRA Pharmaceuticals Submits IND for Ketamir-2 to FDA, Marking a Significant Milestone in the Company's Pipeline Development Newswire
19-Dec-2024 Pharma prepares for CDMO growth in 2025 as CPHI Milan reports record attendance defacto
19-Dec-2024 Pharmapack Announces 2025 Pharmapack Award Finalists defacto
17-Dec-2024 PillSafe Founders' Interview Featured on Bloomberg, Fox Business, and Nasdaq Newswire
16-Dec-2024 Scailyte and Visterra Partner to Advance Autoimmune Disease Research Newswire
12-Dec-2024 Introducing the HyperCAM Delta: The Revolutionary High Throughput HD-MEA, for Faster, More Accurate Data Collection Newswire
12-Dec-2024 Coronado Research announce appointment of Dr Jennifer Bradford as VP, Head of Data Science Coronado Research
12-Dec-2024 Rancho BioSciences, LLC Awarded Great Place to Work(R) Certification for the Third Consecutive Year Newswire
12-Dec-2024 Telomir Pharmaceuticals Raises $1 Million at $7 per Share in a No-Warrant, Restricted Common Stock Deal, Representing a 20% Premium to Closing Price Newswire
11-Dec-2024 Belhaven Biopharma Set to Unveil Promising Nasdepi(R) Data at DDL 2024 Newswire
11-Dec-2024 CARDIO inCode Publication in International Journal of Cardiology Cardiovascular Risk and Prevention Newswire
10-Dec-2024 MIRA Pharmaceuticals Validates Ketamir-2's Safety Profile With No Adverse Findings, Paving the Way for IND Submission by Year-End Newswire
10-Dec-2024 Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS) Newswire
10-Dec-2024 ASBM Responds to PCMA: Put Patients First, Not PBM Profits Newswire
09-Dec-2024 Phastar Scoops Prestigious 2024 Scrip Award Phastar
06-Dec-2024 Empowering Community Pharmacies: myphysician360 and KARE PharmTech Announce Strategic Partnership Newswire